KLP Kapitalforvaltning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419M Buy
361,999
+13,760
+4% +$16.2M 1.3% 11
2026
Q2
$418M Buy
348,239
+30,360
+10% +$31M 1.35% 11
2026
Q1
$292M Buy
317,879
+9,600
+3% +$9.7M 1.15% 12
2025
Q4
$331M Buy
308,279
+3,560
+1% +$3.4M 1.28% 11
2025
Q3
$233M Buy
304,719
+700
+0.2% +$521K 0.92% 13
2025
Q2
$237M Buy
304,019
+10,000
+3% +$7.77M 1.02% 14
2025
Q1
$243M Buy
294,019
+5,100
+2% +$4.24M 1.19% 13
2024
Q4
$223M Buy
+288,919
New +$239M 1.06% 11

Other funds holding LLY

KLP Kapitalforvaltning's LLY Position: Q3 2026 in Review

KLP Kapitalforvaltning increased its Eli Lilly (LLY) stake by 4% in Q3 2026, buying an estimated $16.2M and bringing the position to 361,999 shares worth $419M. The position accounts for 1.3% of the portfolio, ranked #11.

KLP Kapitalforvaltning first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • KLP Kapitalforvaltning held 361,999 shares of Eli Lilly worth $419M as of Q3 2026.
  • KLP Kapitalforvaltning bought 13,760 Eli Lilly shares in Q3 2026, an estimated $16.2M.
  • Eli Lilly made up 1.3% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #11 holding.
  • KLP Kapitalforvaltning first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.